Srinivas Murthy

Has grant

Associate Professor

The University of British Columbia

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Srinivas Murthy is an Associate Professor at the University of British Columbia, Canada. His research focuses on emergency medicine, pediatric critical care, and research ethics, particularly in the context of multi-jurisdictional clinical trials. Recent publications have explored topics such as adaptive platform trials, antimicrobial treatment in pediatric infections, and innovative management approaches in resource-limited settings.

Recent Grants

Grant: Close

Canadian Treatments for COVID-19: SOLIDARITY

Open Date: 2020-05-01

Close Date: 2020-09-30

Grant: Close

Sex as a Biological Variable Supplement - Host Response Mediators in Coronavirus (COVID-19) Infection

Open Date: 2020-05-01

Close Date: 2021-04-30

Grant: Close

Host Response Mediators in Coronavirus (COVID-19) Infection

Open Date: 2020-04-01

Close Date: 2021-09-30

Grant: Close

COVID-19 Ring-based Prevention trial for Undermining Spread (CORPUS)

Open Date: 2020-04-01

Close Date: 2022-03-31

Grant: Close

Socio-Cultural Implications of COVID-19: Educating, Engaging & Empowering the Public

Open Date: 2020-03-01

Close Date: 2022-02-28

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (44)

Fuad Alnaji

Assistant Professor of Pediatrics

University of Ottawa

CANADA

Srinivas Murthy

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

CAEP 2024 Academic Symposium: adaptive platform trials in emergency medicine in Canada

Pediatric critical care capacity in Canada

At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial

Research Ethics Oversight for Multi-jurisdictional Clinical Trials in Canada: A Historical Perspective to Inform Future Direction

Attributable climate emissions: an important public- and patient-centered outcome for intensive care trials

Adapted approaches to initial fluid management of patients with major burns in resource-limited settings: A systematic review

An Equity, Diversity, and Inclusion glossary for sociodemographic determinants of health within critical care medicine,Un glossaire tenant compte de l’équité, de la diversité et de l’inclusion pour les déterminants sociodémographiques de la santé en médecine des soins intensifs

Association of delayed adequate antimicrobial treatment and organ dysfunction in pediatric bloodstream infections

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Designing a national pediatric critical care database: a Delphi consensus study.

Continuation of therapeutic dose heparin for critically ill patients with COVID-19

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized with COVID-19: A Randomized Clinical Trial

Correction: Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies (Critical Care, (2023), 27, 1, (3), 10.1186/s13054-022-04294-5)

Canadian Critical Care Society position statement on Equity, Diversity, Decolonization, and Inclusion,Énoncé de position de la Société canadienne de soins intensifs sur l’équité, la diversité, l’inclusion et la décolonisation

Cardiac and vascular serious adverse events following tixagevimab–cilgavimab

Co-designing and pilot testing an infographic to support patients/families through the REMAP-CAP consent process: a mixed-methods study protocol

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

Collaborators (44)

Fuad Alnaji

Daniel Munblit

Maia Rabaa

Tonny Veenith

Antonia Ho

Barbara Wanjiru Citarella

Brenda Molloy

Todd Karsies

Ilka Engelmann

Thomas Hills

Nicolas TERZI

John Laffey

Wael Haddara

Laura Merson

Melissa Joy Parker

Shirin Golchi

Carlos Lumbreras

Professor Warwick Butt

Antonio Loforte

Ben Morton

Lise Estcourt

Dominique Costagliola

Ewen Harrison

Demetrios Kutsogiannis

Gabriella Lindergard

Charlotte A. Bradbury

Dave Nagpal

Elisabeth Adam

Susanne Gjeruldsen Dudman

ISARIC Clinical Characterisation Group

João João Mendes

Eric D'Ortenzio

Kalynn Kennon

Amanda Rojek

Anders Benjamin Kildal

Brian W Johnston

Andreas Lind

Edward Fysh

Agnès Sommet

Nina Jamieson

Tjard Schermer

Rebecca Cusack

Claudia dos Santos

Victoria Janes

Make your next move.